Alonso PL, Tanner M. Public health challenges and prospects for malaria control and elimination. Nat Med. 2013;19:150–5.
WHO. World Malaria Report 2020. Geneva: World Health Organization; 2021.
WHO. Strategy for malaria elimination in the Greater Mekong Subregion: 2015–2030. Geneva: World Health Organization; 2015.
Geng T, Malla P, Zhang Q, Xu S, Li C, Zhao Y, et al. Increasing trends of malaria in a border area of the Greater Mekong Subregion. Malar J. 2019;18:309.
Cao J, Newby G, Cotter C, Hsiang M, Larson E, Tatarsky A, et al. Achieving malaria elimination in China 2021. Lancet Public Health. 2021;6:e871-872.
Morillon M, Baudon D, Dai B. [Malaria in Vietnam in 1996: brief synthesis of epidemiological data] (in French). Med Trop (Mars). 1996;56:197–200.
Thanh PV, Hong NV, Van NV, Malderen CV, Obsomer V, Urgell AR, et al. Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir. Malar J. 2015;14:86.
Kounnavong S, Gopinath D, Hongvanthong B, Khamkong C, Sichanthongthip O. Malaria elimination in Lao PDR: the challenges associated with population mobility. Infec Dis Poverty. 2017;6:81.
Xu JW, Li JJ, Guo HP, Pu SW, Li SM, Wang RH, et al. Malaria from hyperendemicity to elimination in Hekou County on China-Vietnam border: an ecological study. Malar J. 2017;16:66.
Xu JW, Li Y, Yang HL, Zhang J, Zhang ZX, Yang YM, et al. Malaria control along China–Myanmar border during 2007–2013: an integrated impact evaluation. Inf Dis Poverty. 2016;5:75.
Xu JW, Lee R, Lin ZR, Zhou YW, Shen HM, Zhou HN, et al. Intensive surveillance, rapid response and border collaboration for malaria elimination: China Yunnan’s ‘“3+1”’ strategy. Malar J. 2021;20:396.
Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013;382:900–16.
Hsiang MS, Hwang J, Kunene S. Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS ONE. 2012;7: e29550.
Xu JW, Liu H, Zhang Y, Guo XR, Wang JZ. Risk factors for border malaria in a malaria elimination setting: a retrospective case-control study in Yunnan. China Am J Trop Med Hyg. 2015;92:546–515.
Liu H, Xu JW, Yang HL, Li Mei, Sun CD, Yin YJ, et al. Investigation and control of a Plasmodium falciparum malaria outbreak in Shan Special Region II of Myanmar along the China-Myanmar Border from June to December 2014. Inf Dis Poverty. 2016;5:32.
Liu H, Xu JW, Xu QZ, Zeng YR. Retrospective analysis of risk factors of slide positivity among febrile patients in the Salween river valley of Shan Special Region II, northern Myanmar. BMC Public Health. 2018;18:560.
Xu JW, Liu H. The challenges of malaria elimination in Yunnan Province, People’s Republic of China. Southeast Asian J Trop Med Public Health. 2012;43:819–24.
Liu H, Xu JW, Bi Y. Malaria burden and treatment targets in Kachin Special Region II, Myanmar from 2008 to 2016: a retrospective analysis. PLoS ONE. 2018;13: e0195032.
Xu JW, Liu H. The relationship of malaria between Chinese side and Myanmar’s five special regions along China-Myanmar border: a linear regression analysis. Malar J. 2016;15:368.
Liu H, Xu JW, Guo XR, Havumaki J, Lin YX, Yu GC, et al. Coverage, use and maintenance of bed nets and related influence factors in Kachin Special Region II, northeastern Myanmar. Malar J. 2015;14:212.
Liu H, Yang H, Xu JW, Wang JZ, Nie RH, Li CF, et al. Artemisinin–naphthoquine combination versus chloroquine–primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province China. Malar J. 2013;12:409.
Xu JW, Xu QZ, Liu H, Zeng YR. Malaria treatment-seeking behaviour and related factors of Wa ethnic minority in Myanmar: a cross-sectional study. Malar J. 2012;11:417.
Liu H, Yang HL, Tang LH, Li XL, Huang F, Wang JZ, et al. Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008–2013. Malar J. 2014;13:364.
Liu H, Yang HL, Tang LH, Li YL, Huang F, Wang JZ, et al. In vivo monitoring of dihydroartemisinin- piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013. Malar J. 2015;14:47.
Zhao X, Thanapongtharm W, Lawawirojwong S, Wei C, Tang Y, Zhou Y, Sun X, et al. Spatiotemporal trends of malaria in relation to economic development and cross-border movement along the China-Myanmar border in Yunnan Province. Korean J Parasitol. 2020;58:267–78.
Zhao X, Lawawirojwong S, Thanapongtharm W, Wei C, Tang Y, Zhou Y, Sun X, et al. Malaria risk map using spatial multi-criteria decision analysis along Yunnan Border during the pre-elimination period. Am J Trop Med Hyg. 2020;103:793–809.
Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21:459–68.
Xu J-W, Liu H, Yaw B, Nbwi HS. The health beliefs, dengue knowledge and control behaviors among internally displaced persons versus local residents in Kachin Special Region II, Myanmar. PLoS Negl Trop Dis. 2020;14: e0008321.
Xu JW, Liu H, Ai D, Yu Y, Yu B. The Shan people’s health beliefs, knowledge and perceptions of dengue in Eastern Shan Special Region IV Myanmar. PLoS Negl Trop Dis. 2019;13: e0007498.
Liu H, Xu JW, Ai Z, et al. Treatment seeking behavior and associated factors of suspected dengue fever among Shan people in eastern Shan special region IV, Myanmar: a cross-sectional study. BMC Health Serv Res. 2020;20:318.
Ward KA, Spokes PJ, McAnulty JM. Case–control study of risk factors hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis. 2011;17:1409–16.
Prothero RM. Malaria, forests and people in Southeast Asia. Singap J Trop Geogr. 1999;20:76–85.
Mekong RBM. Mekong Malaria II: update of malaria, multi-resistance and economic development in the Mekong Region of Southeast Asia. Southeast Asian J Trop Med Public Health. 2003;34(Suppl):68–70.
Guerra CA, Snow RW, Hay SR. A global assessment of closed forests, deforestation and malaria risk. Ann Trop Med Parasitol. 2006;100:189–204.
Erhart A, Thang ND, Ky PV, Tinh TT, Overmeir CV, Speybroeck N, et al. Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malar J. 2005;4:58.
Delacollette C, Souza C, Christophe E, Thimasarn K, Abdur R, Bell D, et al. Malaria trends and challenges in the greater Mekong Subregion. Southeast Asian J Trop Med Public Health. 2009;40:674–91.
Dunning J, Aung NKZ, Ward A, Aye MM, Lourenço C, Gallalee S, et al. Key factors associated with malaria infection among patients seeking care through the public sector in endemic townships of Ayeyarwady Region Myanmar. Malar J. 2022;21:86.
Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, et al. Malaria in the Greater Mekong Subregion: heterogeneity and complexity. Acta Trop. 2012;121:227–39.
WHO. Malaria elimination: a field manual for low and moderate endemic countries. Geneva: World Health Organization; 2014.
WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017.
Zhao X, Sun X, Yang H, Zhou D, Yang J, Guo T, et al. A report of the last indigenous malaria case in Yunnan (in Chinese). China Trop Med. 2020;20:325–8.
Xu JW, Lee R, Li X, Liu H. Transition of radical, preventive and presumptive treatment regimens for malaria in China: a systematic review. Malar J. 2021;20:10.